Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Masimo Corp MASI

Healthcare Medical Devices
Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital... see more

Recent & Breaking News (NDAQ:MASI)

Masimo Announces FDA Clearance of the Rad-67™ Pulse CO-Oximeter® with Next Generation SpHb® Spot-check Monitoring & rainbow® DCI®-mini Reusable Sensor

Business Wire March 25, 2019

The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback

Benzinga.com  March 22, 2019

St. Luke’s University Health Network Achieves Compelling Outcome Results Following Implementation of Masimo Supplemental Remote Monitoring Solution

Business Wire March 19, 2019

Masimo to Present at Barclays Global Healthcare Conference

Business Wire March 6, 2019

Masimo annonce le marquage CE pour le monitorage de la fonction cérébrale SedLine® de nouvelle génération à usage pédiatrique

Business Wire March 5, 2019

Masimo Announces CE Marking of Pediatric Indication for Next Generation SedLine® Brain Function Monitoring

Business Wire March 4, 2019

Masimo to Present at Raymond James 40th Annual Institutional Investors Conference

Business Wire February 27, 2019

Masimo Reports Fourth Quarter and Full Year 2018 Financial Results

Business Wire February 26, 2019

Une nouvelle série de cas examine l’utilisation combinée de surveillance de la fonction cérébrale SedLine® et de l’oxymétrie régionale pendant la chirurgie cardiaque O3®de Masimo

Business Wire February 26, 2019

New Case Series Investigates the Combined Use of Masimo SedLine® Brain Function Monitoring and O3® Regional Oximetry During Cardiac Surgery

Business Wire February 25, 2019

Saudi Arabia Ministry of Health and Masimo Announce Automation of National Neonatal CCHD Screening Process Using Masimo Technology

Business Wire February 18, 2019

Le ministère saoudien de la Santé et Masimo annoncent l’automatisation du processus national de dépistage des cardiopathies congénitales critiques néonatales, au moyen de la technologie Masimo

Business Wire February 18, 2019

The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J's Depression Drug, MacroGenics Prices Offering

Benzinga.com  February 13, 2019

Masimo Announces Doctella™, a Secure Cloud-based Patient Engagement and Remote Care Automation Platform

Business Wire February 11, 2019

New Research Coverage Highlights New Residential Investment, KLA-Tencor, Masimo, Schneider National, Enova International, and New Media Investment Group — Consolidated Revenues, Company Growth, and Expectations for 2019

GlobeNewswire February 6, 2019

Masimo Announces FDA Clearance of RRp®, Respiration Rate from the Pleth, on the MightySat™ Rx Spot-Check Fingertip Pulse Oximeter

Business Wire January 28, 2019

Masimo Announces U.S. Launch of Iris® Device Management System

Business Wire January 22, 2019

Masimo Announces Select Preliminary Full Year 2018 Financial Results and 2019 Outlook

Business Wire January 9, 2019

Julie A. Shimer Ph.D. Joins Masimo’s Board of Directors

Business Wire January 7, 2019

New Research Coverage Highlights LKQ, Pacira Pharmaceuticals, WellCare Health Plans, Masimo, Workday, and Potbelly — Consolidated Revenues, Company Growth, and Expectations for 2019

GlobeNewswire January 4, 2019